Publications

1. Grenville ZS, Noor U, Rinaldi S, Gunter MJ, Ferrari P, Agnoli C, et al. (2025). Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case-control sets from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 156(5): 943-952. https://doi.org/10.1002/ijc.35208 PMID: 39378119
2. Werr L, Bartenhagen C, Rosswog C, Cartolano M, Voegele C, Sexton-Oates A, et al. (2025). TERT Expression and Clinical Outcome in Pulmonary Carcinoids. J Clin Oncol. 43(2): 214-225. https://doi.org/10.1200/JCO.23.02708 PMID: 39348606
3. Zeng Y, Luo CL, Lin GW, Li F, Bai X, Ko JM, et al. (2025). Whole-exome sequencing association study reveals genetic effects on tumor microenvironment components in nasopharyngeal carcinoma. J Clin Invest. 135(1). https://doi.org/10.1172/JCI182768 PMID: 39744943
4. Alcala N, Voegele C, Mangiante L, Sexton-Oates A, Clevers H, Fernandez-Cuesta L, et al. (2024). Multi-omic dataset of patient-derived tumor organoids of neuroendocrine neoplasms. Gigascience. 13: 13. https://doi.org/10.1093/gigascience/giae008 PMID: 38451475
5. Ambriz-Barrera F, Rojas-Jimenez E, Diaz-Velasquez CE, De-La-Cruz-Montoya AH, Martinez-Gregorio H, Ruiz-De-La-Cruz M, et al. (2024). Mutational spectrum of breast cancer by shallow whole-genome sequencing of cfDNA and tumor gene panel analysis. PLoS One. 19(9): e0308176. https://doi.org/10.1371/journal.pone.0308176 PMID: 39264897
6. Bakhshimoghaddam F, Baez D, Dolatkhah N, Sheikh M, Poustchi H, Hekmatdoost A, et al. (2024). Which dietary patterns fend off nonalcoholic fatty liver disease? A systematic review of observational and interventional studies. BMC Nutr. 10(1): 153. https://doi.org/10.1186/s40795-024-00961-8 PMID: 39609906
7. Beigrezaei S, Dianati M, Salehi-Abargouei A, Fararouei M, Akbari-Beni A, Brinkman M, et al. (2024). The association between animal protein, plant protein, and their substitution with bladder cancer risk: a pooled analysis of 10 cohort studies. Eur J Nutr. 64(1): 55. https://doi.org/10.1007/s00394-024-03551-3 PMID: 39718625
8. Borgmastars E, Jacobson S, Simm M, Johansson M, Billing O, Lundin C, et al. (2024). Metabolomics for early pancreatic cancer detection in plasma samples from a Swedish prospective population-based biobank. J Gastrointest Oncol. 15(2): 755-767. https://doi.org/10.21037/jgo-23-930 PMID: 38756646
9. Borgmastars E, Ulfenborg B, Johansson M, Jonsson P, Billing O, Franklin O, et al. (2024). Multi-omics profiling to identify early plasma biomarkers in pre-diagnostic pancreatic ductal adenocarcinoma: a nested case-control study. Transl Oncol. 48: 102059. https://doi.org/10.1016/j.tranon.2024.102059 PMID: 39018772
10. Bouras E, Gill D, Zuber V, Murphy N, Dimou N, Aleksandrova K, et al. (2024). Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis. Int J Epidemiol. 53(3). https://doi.org/10.1093/ije/dyae067 PMID: 38725300
11. Bull CJ, Hazelwood E, Legge DN, Corbin LJ, Richardson TG, Lee M, et al. (2024). Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes. EBioMedicine. 100: 104977. https://doi.org/10.1016/j.ebiom.2024.104977 PMID: 38290287
12. Caramenti L, Gradowska PL, Morina D, Byrnes G, Cardis E, Hauptmann M (2024). Finite-Sample Bias of the Linear Excess Relative Risk in Cohort Studies of Computed Tomography-Related Radiation Exposure and Cancer. Radiat Res. 201(3): 206-214. https://doi.org/10.1667/RADE-23-00187.1 PMID: 38323646
13. Chavanel B, Virard F, Cahais V, Renard C, Sirand C, Smits KM, et al. (2024). Genome-scale mutational signature analysis in archived fixed tissues. Mutat Res Rev Mutat Res. 794: 108512. https://doi.org/10.1016/j.mrrev.2024.108512 PMID: 39216514
14. Chen T, Pham G, Fox L, Adler N, Wang X, Zhang J, et al. (2024). Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices. EBioMedicine. 110: 105441. https://doi.org/10.1016/j.ebiom.2024.105441 PMID: 39520911
15. Cheng TS, Noor U, Watts E, Pollak M, Wang Y, McKay J, et al. (2024). Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition. BMC Cancer. 24(1): 676. https://doi.org/10.1186/s12885-023-11425-w PMID: 38831273
16. Cornish N, Haycock P, Brenner H, Figueiredo JC, Galesloot TE, Grant RC, et al. (2024). Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysis. Int J Epidemiol. 53(1): 11. https://doi.org/10.1093/ije/dyad170 PMID: 38124529
17. Cortez Cardoso Penha R, Sexton Oates A, Senkin S, Park HA, Atkins J, Holcatova I, et al. (2024). Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach. Mol Syst Biol. 20(12): 1282-1302. https://doi.org/10.1038/s44320-024-00072-3 PMID: 39592856
18. Cruz-Romero SD, Gonzalez S, Juez JY, Becerra DS, Baldion AM, Hakim JA, et al. (2024). TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary Thyroid Carcinoma in a Colombian Cohort. Adv Ther. 41(2): 792-805. https://doi.org/10.1007/s12325-023-02756-y PMID: 38170436
19. Desai TA, Hedman AK, Dimitriou M, Koprulu M, Figiel S, Yin W, et al. (2024). Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics. EBioMedicine. 105: 105168. https://doi.org/10.1016/j.ebiom.2024.105168 PMID: 38878676
20. Du M, Xin J, Zheng R, Yuan Q, Wang Z, Liu H, et al. (2024). CYP2A6 Activity and Cigarette Consumption Interact in Smoking-Related Lung Cancer Susceptibility. Cancer Res. 84(4): 616-625. https://doi.org/10.1158/0008-5472.CAN-23-0900 PMID: 38117513
21. Dunlop KLA, Singh N, Robbins HA, Zahed H, Johansson M, Rankin NM, et al. (2024). Implementation considerations for risk-tailored cancer screening in the population: A scoping review. Prev Med. 181: 107897. https://doi.org/10.1016/j.ypmed.2024.107897 PMID: 38378124
22. Engels EA, Shiels MS, Barnabas RV, Bohlius J, Brennan P, Castilho J, et al. (2024). State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCI. Int J Cancer. 154(4): 596-606. https://doi.org/10.1002/ijc.34727 PMID: 37715370
23. Etemadi A, Poustchi H, Chang CM, Calafat AM, Blount BC, Bhandari D, et al. (2024). Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer. J Natl Cancer Inst. 116(3): 379-388. https://doi.org/10.1093/jnci/djad218 PMID: 37856326
24. Feng X, Goodley P, Alcala K, Guida F, Kaaks R, Vermeulen R, et al. (2024). Evaluation of risk prediction models to select lung cancer screening participants in Europe: a prospective cohort consortium analysis. Lancet Digit Health. 6(9): e614-e624. https://doi.org/10.1016/S2589-7500(24)00123-7 PMID: 39179310
25. Feng X, Robbins HA, Mukeriya A, Foretova L, Holcatova I, Janout V, et al. (2024). Prognostic value of circulating proteins at diagnosis among patients with lung cancer: a comprehensive analysis by smoking status. Transl Lung Cancer Res. 13(9): 2326-2339. https://doi.org/10.21037/tlcr-24-242 PMID: 39430322
26. Feng X, Zahed H, Onwuka J, Callister MEJ, Johansson M, Etzioni R, et al. (2024). Cancer Stage Compared With Mortality as End Points in Randomized Clinical Trials of Cancer Screening: A Systematic Review and Meta-Analysis. JAMA. 331(22): 1910-1917. https://doi.org/10.1001/jama.2024.5814 PMID: 38583868
27. Gorman BR, Ji SG, Francis M, Sendamarai AK, Shi Y, Devineni P, et al. (2024). Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk. Nat Commun. 15(1): 8629. https://doi.org/10.1038/s41467-024-52129-4 PMID: 39366959
28. Grassmann F, Malarstig A, Dahl L, Bendes A, Dale M, Thomas CE, et al. (2024). The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk. Br J Cancer. 130(4): 620-627. https://doi.org/10.1038/s41416-023-02541-2 PMID: 38135714
29. Gustafsson S, Lampa E, Jensevik Eriksson K, Butterworth AS, Elmstahl S, Engstrom G, et al. (2024). Markers of imminent myocardial infarction. Nat Cardiovasc Res. 3(2): 130-139. https://doi.org/10.1038/s44161-024-00422-2 PMID: 39196201
30. Inoue-Choi M, Freedman ND, Etemadi A, Hashemian M, Brennan P, Roshandel G, et al. (2024). One-carbon metabolism biomarkers and upper gastrointestinal cancer in the Golestan Cohort Study. Int J Cancer. 155(11): 1944-1957. https://doi.org/10.1002/ijc.35115 PMID: 39109892
31. Johansson M, Robbins HA (2024). Harnessing population-wide health data to predict cancer risk. Lancet Digit Health. 6(6): e377-e378. https://doi.org/10.1016/S2589-7500(24)00093-1 PMID: 38789137
32. Kearney LE, Belancourt P, Katki HA, Tanner NT, Wiener RS, Robbins HA, et al. (2024). The Development and Performance of Alternative Criteria for Lung Cancer Screening. Ann Intern Med. 177(9): 1222-1232. https://doi.org/10.7326/M23-3250 PMID: 39159457
33. Koca D, Abedi-Ardekani B, LeMaoult J, Guyon L (2024). Peritumoral tissue (PTT): increasing need for naming convention. Br J Cancer. 131(7): 1111-1115. https://doi.org/10.1038/s41416-024-02828-y PMID: 39223304
34. Koumarianou A, Filosso PL, Bodei L, Castano JP, Fernandez-Cuesta L, Deroose CM, et al. (2024). Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force. J Neuroendocrinol. 36(8): e13412. https://doi.org/10.1111/jne.13412 PMID: 38754956
35. Koyanagi YN, Nakatochi M, Namba S, Oze I, Charvat H, Narita A, et al. (2024). Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Sci Adv. 10(4): eade2780. https://doi.org/10.1126/sciadv.ade2780 PMID: 38277453
36. Kusters JMA, Diergaarde B, Ness A, Schim van der Loeff MF, Heijne JCM, Schroeder L, et al. (2024). Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex. Int J Cancer. 154(2): 389-402. https://doi.org/10.1002/ijc.34710 PMID: 37694289
37. Lam S, Bai C, Baldwin DR, Chen Y, Connolly C, de Koning H, et al. (2024). Current and Future Perspectives on Computed Tomography Screening for Lung Cancer: A Roadmap From 2023 to 2027 From the International Association for the Study of Lung Cancer. J Thorac Oncol. 19(1): 36-51. https://doi.org/10.1016/j.jtho.2023.07.019 PMID: 37487906
38. Li Y, Xiao X, Li J, Han Y, Cheng C, Fernandes GF, et al. (2024). Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies. Cancer Epidemiol Biomarkers Prev. 33(3): 389-399. https://doi.org/10.1158/1055-9965.EPI-23-0613 PMID: 38180474
39. Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al. (2024). Latin American Consensus on the Treatment of Head and Neck Cancer. JCO Glob Oncol. 10: e2300343. https://doi.org/10.1200/GO.23.00343 PMID: 38603656
40. Moen CA, Falkenthal TE, Thorkelsen TK, Hopland A, Rio OE, Honore A, et al. (2024). Penile Cancers Attributed to Human Papillomavirus Are Associated with Improved Survival for Node-positive Patients. Findings from a Norwegian Cohort Study Spanning 50 Years. Eur Urol Oncol. 7(4): 778-785. https://doi.org/10.1016/j.euo.2023.10.013 PMID: 37949729
41. Moirangthem R, Hosseini B, Patil A, George GS, Manjrekar A, Doibale P, et al. (2024). Occupations and the risk of buccal mucosa cancer in Indian men: A multi-centre case-control study. Cancer Epidemiol. 92: 102644. https://doi.org/10.1016/j.canep.2024.102644 PMID: 39153274
42. Morales-Berstein F, Biessy C, Viallon V, Goncalves-Soares A, Casagrande C, Hemon B, et al. (2024). Ultra-processed foods, adiposity and risk of head and neck cancer and oesophageal adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition study: a mediation analysis. Eur J Nutr. 63(2): 377-396. https://doi.org/10.1007/s00394-023-03270-1 PMID: 37989797
43. Nalini M, Poustchi H, Bhandari D, Chang CM, Blount BC, Wang L, et al. (2024). Volatile organic compounds and mortality from ischemic heart disease: A case-cohort study. Am J Prev Cardiol. 19: 100700. https://doi.org/10.1016/j.ajpc.2024.100700 PMID: 39100747
44. Nemati S, Dardashti AR, Mohebbi E, Kamangar F, Malekzadeh R, Zendehdel K, et al. (2024). Potential impact of controlling opium use prevalence on future cancer incidence in Iran. EClinicalMedicine. 73: 102650. https://doi.org/10.1016/j.eclinm.2024.102650 PMID: 38881571
45. Nemati S, Islami F, Kamangar F, Poustchi H, Roshandel G, Shakeri R, et al. (2024). Improvement of esophageal cancer survival in Northeast Iran: A two-decade journey in a high-risk, low- resource region. PLoS One. 19(9): e0310842. https://doi.org/10.1371/journal.pone.0310842 PMID: 39321196
46. Ni Z, Kundu P, McKean DF, Wheeler W, Albanes D, Andreotti G, et al. (2024). Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Cancer Epidemiol Biomarkers Prev. 33(9): 1229-1239. https://doi.org/10.1158/1055-9965.EPI-24-0096 PMID: 38869494
47. Onwuka JU, Wuraola FO, Owoade IA, Ogunyemi YF, Di Bernardo M, Dare AJ, et al. (2024). Delays in Presentation, Diagnosis, and Treatment Among Patients With GI Cancer in Southwest Nigeria. JCO Glob Oncol. 10: e2400060. https://doi.org/10.1200/GO.24.00060 PMID: 39418630
48. Orive D, Echepare M, Bernasconi-Bisio F, Sanmamed MF, Pineda-Lucena A, de la Calle-Arroyo C, et al. (2024). Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment. Arch Bronconeumol. 60 Suppl 2: S67-S76. https://doi.org/10.1016/j.arbres.2024.07.007 PMID: 39079848
49. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. (2024). The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 4(3): 100500. https://doi.org/10.1016/j.xgen.2024.100500 PMID: 38325367
50. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, et al. (2024). Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 56(5): 809-818. https://doi.org/10.1038/s41588-024-01725-7 PMID: 38671320
51. Rabien A, Rong D, Rabenhorst S, Schlomm T, Labonte F, Hofbauer S, et al. (2024). Diagnostic performance of Uromonitor and TERTpm ddPCR urine tests for the non-invasive detection of bladder cancer. Sci Rep. 14(1): 30617. https://doi.org/10.1038/s41598-024-83976-2 PMID: 39715826
52. Reddy SSP, Francis DL, Kulkarni V, Chopra SS (2024). Letter to editor on ‘isolation and characterization of human Wharton’s jelly mesenchymal stem cell-derived extracellular vesicles’. J Cell Mol Med. 28(20): e70168. https://doi.org/10.1111/jcmm.70168 PMID: 39438269
53. Robbins HA (2024). Multicancer Early Detection Tests – Keeping a High Bar for Evidence of Benefit. N Engl J Med. 391(4): 292-294. https://doi.org/10.1056/NEJMp2400297 PMID: 39037048
54. Robbins HA, Feng X, Etzioni R (2024). Cancer Stage vs Mortality End Points in Randomized Clinical Trials of Cancer Screening. JAMA. 332(14): 2. https://doi.org/10.1001/jama.2024.16365 PMID: 39264595
55. Ruiz-De La Cruz M, Martinez-Gregorio H, Estela Diaz-Velasquez C, Ambriz-Barrera F, Resendiz-Flores NG, Gitler-Weingarten R, et al. (2024). Methylation marks in blood DNA reveal breast cancer risk in patients fulfilling hereditary disease criteria. NPJ Precis Oncol. 8(1): 136. https://doi.org/10.1038/s41698-024-00611-z PMID: 38898118
56. Senkin S, Moody S, Diaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. (2024). Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 629(8013): 910-918. https://doi.org/10.1038/s41586-024-07368-2 PMID: 38693263
57. Smith CDL, McMahon AD, Lyall DM, Goulart M, Inman GJ, Ross A, et al. (2024). Development and external validation of a head and neck cancer risk prediction model. Head Neck. 46(9): 2261-2273. https://doi.org/10.1002/hed.27834 PMID: 38850089
58. Smith-Byrne K, Hedman A, Dimitriou M, Desai T, Sokolov AV, Schioth HB, et al. (2024). Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers. Nat Commun. 15(1): 3621. https://doi.org/10.1038/s41467-024-46834-3 PMID: 38684708
59. Thakral A, Lee JJ, Hou T, Hueniken K, Dudding T, Gormley M, et al. (2024). Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun. 15(1): 7835. https://doi.org/10.1038/s41467-024-51679-x PMID: 39244563
60. Tietze A, Bison B, European Society for Paediatric Oncology -Brain Tumour G, Engelhardt J, Fenouil T, Figarella-Branger D, et al. (2024). CNS Embryonal Tumor with PLAGL Amplification, a New Tumor Type in Children and Adolescents: Insights from a Comprehensive MRI Analysis. AJNR Am J Neuroradiol. https://doi.org/10.3174/ajnr.A8496 PMID: 39271290
61. Viallon V, Freisling H, Matta K, Nannsen AO, Dahm CC, Tjonneland A, et al. (2024). On the use of the healthy lifestyle index to investigate specific disease outcomes. Sci Rep. 14(1): 16330. https://doi.org/10.1038/s41598-024-66772-w PMID: 39009699
62. Wang X, Zhang Z, Ding Y, Chen T, Mucci L, Albanes D, et al. (2024). Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification. Genome Med. 16(1): 22. https://doi.org/10.1186/s13073-024-01298-4 PMID: 38317189
63. Watts EL, Gonzales TI, Strain T, Saint-Maurice PF, Bishop DT, Chanock SJ, et al. (2024). Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study. Br J Cancer. 130(1): 114-124. https://doi.org/10.1038/s41416-023-02489-3 PMID: 38057395
64. Whitham L, Sheikh M, Hollmann MW, Parat MO (2024). The Comparative Effect of Morphine on Proliferation of Cancer Cell Lines Originating from Different Organs: An In Vitro Study. Pharmaceuticals (Basel). 17(12). https://doi.org/10.3390/ph17121656 PMID: 39770497
65. Xu W, Gaborieau V, Niman SM, Mukeria A, Liu X, Maremanda KP, et al. (2024). Plasma Kidney Injury Molecule-1 for Preoperative Prediction of Renal Cell Carcinoma Versus Benign Renal Masses, and Association With Clinical Outcomes. J Clin Oncol. 42(22): 2691-2701. https://doi.org/10.1200/JCO.23.00699 PMID: 38701382
66. Yang JJ, Wen W, Zahed H, Zheng W, Lan Q, Abe SK, et al. (2024). Lung Cancer Risk Prediction Models for Asian Ever-Smokers. J Thorac Oncol. 19(3): 451-464. https://doi.org/10.1016/j.jtho.2023.11.002 PMID: 37944700
67. Yano Y, Abnet CC, Roshandel G, Graf A, Poustchi H, Khoshnia M, et al. (2024). Dental health and lung cancer risk in the Golestan Cohort Study. BMC Cancer. 24(1): 74. https://doi.org/10.1186/s12885-024-11850-5 PMID: 38218793
68. Yarmolinsky J, Robinson JW, Mariosa D, Karhunen V, Huang J, Dimou N, et al. (2024). Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis. EBioMedicine. 100: 104991. https://doi.org/10.1016/j.ebiom.2024.104991 PMID: 38301482
69. Yazdanpanah MH, Sharafkhah M, Poustchi H, Etemadi A, Sheikh M, Kamangar F, et al. (2024). Mineral Intake and Cardiovascular Disease, Cancer, and All-Cause Mortality: Findings from the Golestan Cohort Study. Nutrients. 16(3): 23. https://doi.org/10.3390/nu16030344 PMID: 38337629
70. Zahed H, Feng X, Sheikh M, Bray F, Ferlay J, Ginsburg O, et al. (2024). Age at diagnosis for lung, colon, breast and prostate cancers: An international comparative study. Int J Cancer. 154(1): 28-40. https://doi.org/10.1002/ijc.34671 PMID: 37615573
71. Zhang Y, Khil J, Feng X, Ugai T, Ogino S, Giovannucci E (2024). Risk of colorectal cancer and adenoma after an appendectomy: results from three large prospective cohort studies and meta-analysis. Cancer Causes Control. 35(11): 1457-1466. https://doi.org/10.1007/s10552-024-01901-4 PMID: 39066935
72. Zhao X, Yang M, Fan J, Wang M, Wang Y, Qin N, et al. (2024). Identification of genetically predicted DNA methylation markers associated with non-small cell lung cancer risk among 34,964 cases and 448,579 controls. Cancer. 130(6): 913-926. https://doi.org/10.1002/cncr.35130 PMID: 38055287
73. Alcala K, Poustchi H, Viallon V, Islami F, Pourshams A, Sadjadi A, et al. (2023). Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study. EClinicalMedicine. 64: 102229. https://doi.org/10.1016/j.eclinm.2023.102229 PMID: 37781157
74. Alcala K, Zahed H, Cortez Cardoso Penha R, Alcala N, Robbins HA, Smith-Byrne K, et al. (2023). Kidney Function and Risk of Renal Cell Carcinoma. Cancer Epidemiol Biomarkers Prev. 32(11): 1644-1650. https://doi.org/10.1158/1055-9965.Epi-23-0558 PMID: 37668600
75. Alcala N, Fernandez-Cuesta LA (2023). Lifting the curtain on molecular differences between malignant pleural mesotheliomas. Nat Genet. 55(4): 540-541. https://doi.org/10.1038/s41588-023-01322-0 PMID: 36928604
76. Arboleda LPA, de Carvalho GB, Santos-Silva AR, Fernandes GA, Vartanian JG, Conway DI, et al. (2023). Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, and Larynx: A Scoping Review of Treatment Guidelines Worldwide. Cancers (Basel). 15(17). https://doi.org/10.3390/cancers15174405 PMID: 37686681
77. Arboleda LPA, Neves AB, Kohler HF, Vartanian JG, Candelaria LM, Borges MF, et al. (2023). Overview of glottic laryngeal cancer treatment recommendation changes in the NCCN guidelines from 2011 to 2022. Cancer Rep (Hoboken). 6(8): e1837. https://doi.org/10.1002/cnr2.1837 PMID: 37288471
78. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2023). Correction: Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 37(10): 2142-2142. https://doi.org/10.1038/s41375-023-01978-x PMID: 37666943
79. Blazquez-Encinas R, Garcia-Vioque V, Caro-Cuenca T, Moreno-Montilla MT, Mangili F, Alors-Perez E, et al. (2023). Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery. J Transl Med. 21(1): 879. https://doi.org/10.1186/s12967-023-04754-8 PMID: 38049848
80. Budhathoki S, Diergaarde B, Liu G, Olshan A, Ness A, Waterboer T, et al. (2023). A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. Int J Cancer. 152(10): 2069-2080. https://doi.org/10.1002/ijc.34444 PMID: 36694401
81. Callister MEJ, Crosbie EJ, Crosbie PAJ, Robbins HA (2023). Evaluating multi-cancer early detection tests: an argument for the outcome of recurrence-updated stage. Br J Cancer. 129(8): 1209-1211. https://doi.org/10.1038/s41416-023-02434-4 PMID: 37726480
82. Casolino R, Johns AL, Courtot M, Lawlor RT, De Lorenzo F, Horgan D, et al. (2023). Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission. Lancet Oncol. 24(2): 123-125. https://doi.org/10.1016/S1470-2045(23)00007-4 PMID: 36725142
83. Cheng C, Hong W, Li Y, Xiao X, McKay J, Han Y, et al. (2023). Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis. J Thorac Oncol. 18(8): 1003-1016. https://doi.org/10.1016/j.jtho.2023.05.001 PMID: 37150255
84. Clasen JL, Mabunda R, Heath AK, Kaaks R, Katzke V, Schulze MB, et al. (2023). Reproductive and hormonal factors and risk of renal cell carcinoma among women in the European Prospective Investigation into Cancer and Nutrition. Cancer Med. 12(14): 15588-15600. https://doi.org/10.1002/cam4.6207 PMID: 37269199
85. Cortez Cardoso Penha R, Smith-Byrne K, Atkins JR, Haycock PC, Kar S, Codd V, et al. (2023). Common genetic variations in telomere length genes and lung cancer: a Mendelian randomisation study and its novel application in lung tumour transcriptome. Elife. 12. https://doi.org/10.7554/eLife.83118 PMID: 37079368
86. Dayton TL, Alcala N, Moonen L, den Hartigh L, Geurts V, Mangiante L, et al. (2023). Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites. Cancer Cell. 41(12): 2083-2099 e2089. https://doi.org/10.1016/j.ccell.2023.11.007 PMID: 38086335
87. Diaz-Gay M, Vangara R, Barnes M, Wang X, Islam SMA, Vermes I, et al. (2023). Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. Bioinformatics. 39(12): 5. https://doi.org/10.1093/bioinformatics/btad756 PMID: 38096571
88. Diaz-Velasquez CE, Gitler R, Antoniano A, Kershenovich Sefchovich R, De La Cruz-Montoya AH, Martinez-Gregorio H, et al. (2023). Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. Front Genet. 14: 1094260. https://doi.org/10.3389/fgene.2023.1094260 PMID: 36845387
89. D’Souza G, Tewari SR, Troy T, Waterboer T, Struijk L, Castillo R, et al. (2023). Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study. Cancer. 129(15): 2373-2384. https://doi.org/10.1002/cncr.34783 PMID: 37032449
90. Dumontet C, Demangel D, Galia P, Karlin L, Roche L, Fauvernier M, et al. (2023). Clinical characteristics and outcome of 318 families with familial monoclonal gammopathy: A multicenter Intergroupe Francophone du Myelome study. Am J Hematol. 98(2): 264-271. https://doi.org/10.1002/ajh.26785 PMID: 36588407
91. Fares AF, Li Y, Jiang M, Brown MC, Lam ACL, Aggarwal R, et al. (2023). Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies. Lancet Public Health. 8(9): E691-E700. https://doi.org/10.1016/S2468-2667(23)00131-7 PMID: 37633678
92. Feng X, Muller DC, Zahed H, Alcala K, Guida F, Smith-Byrne K, et al. (2023). Evaluation of pre-diagnostic blood protein measurements for predicting survival after lung cancer diagnosis. EBioMedicine. 92: 104623. https://doi.org/10.1016/j.ebiom.2023.104623 PMID: 37236058
93. Feng X, Wu WY, Onwuka JU, Haider Z, Alcala K, Smith-Byrne K, et al. (2023). Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools. J Natl Cancer Inst. 115(9): 1050-1059. https://doi.org/10.1093/jnci/djad071 PMID: 37260165
94. Feng X, Zhang Y, Vaselkiv JB, Li R, Nguyen PL, Penney KL, et al. (2023). Modifiable risk factors for subsequent lethal prostate cancer among men with an initially negative prostate biopsy. Br J Cancer. 129(12): 1988-2002. https://doi.org/10.1038/s41416-023-02472-y PMID: 37898724
95. Fernandez-Cuesta L, Sexton-Oates A, Bayat L, Foll M, Lau SCM, Leal T (2023). Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms. Am Soc Clin Oncol Educ Book. 43: e390794. https://doi.org/10.1200/EDBK_390794 PMID: 37229617
96. Garcia-Pardo M, Chang A, Schmid S, Dong M, Brown MC, Christiani D, et al. (2023). Respiratory and Cardiometabolic Comorbidities and Stages I to III NSCLC Survival: A Pooled Analysis From the International Lung Cancer Consortium. J Thorac Oncol. 18(3): 313-323. https://doi.org/10.1016/j.jtho.2022.10.020 PMID: 36396063
97. Goyal N, Hennessy M, Lehman E, Lin W, Agudo A, Ahrens W, et al. (2023). Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium. Oral Dis. 29(4): 1565-1578. https://doi.org/10.1111/odi.14196 PMID: 35322907
98. Hadji M, Marzban M, Rashidian H, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2023). Opium use and risk of colorectal cancer: a multi-center case-referent study in Iran. Acta Oncol. 62(12): 1661-1668. https://doi.org/10.1080/0284186X.2023.2276326 PMID: 37934078
99. Haycock PC, Borges MC, Burrows K, Lemaitre RN, Harrison S, Burgess S, et al. (2023). Design and quality control of large-scale two-sample Mendelian randomization studies. Int J Epidemiol. 52(5): 1498-1521. https://doi.org/10.1093/ije/dyad018 PMID: 38587501
100. Hosseini E, Mokhtari Z, Poustchi H, Khoshnia M, Dawsey SM, Boffetta P, et al. (2023). Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study. Int J Environ Res Public Health. 20(5): 3788. https://doi.org/10.3390/ijerph20053788 PMID: 36900799
101. Khan SM, Das T, Chakraborty S, Choudhury A, Karim HF, Mostofa MA, et al. (2023). A transcriptome study of p53-pathway related prognostic gene signature set in bladder cancer. Heliyon. 9(10): e21058. https://doi.org/10.1016/j.heliyon.2023.e21058 PMID: 37876438
102. Khodayari Moez E, Warkentin MT, Brhane Y, Lam S, Field JK, Liu G, et al. (2023). Circulating proteome for pulmonary nodule malignancy. J Natl Cancer Inst. 115(9): 1060-1070. https://doi.org/10.1093/jnci/djad122 PMID: 37369027
103. King SD, Veliginti S, Brouwers M, Ren Z, Zheng W, Setiawan VW, et al. (2023). Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Cancer Epidemiol Biomarkers Prev. 32(9): 1265-1269. https://doi.org/10.1158/1055-9965.EPI-23-0453 PMID: 37351909
104. Kolijn PM, Späth F, Khouja M, Hengeveld PJ, van der Straten L, Darzentas N, et al. (2023). Genetic drivers in the natural history of chronic lymphocytic leukemia development as early as 16 years before diagnosis. Blood. 142(16): 1399-1403. https://doi.org/10.1182/blood.2023019609 PMID: 37523714
105. Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, et al. (2023). Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. Eur Urol. 84(1): 127-137. https://doi.org/10.1016/j.eururo.2023.04.020 PMID: 37210288
106. Landy R, Gomez I, Caverly TJ, Kawamoto K, Rivera MP, Robbins HA, et al. (2023). Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility. Jama Network Open. 6(9): e2331155. https://doi.org/10.1001/jamanetworkopen.2023.31155 PMID: 37721755
107. Landy R, Wang VL, Baldwin DR, Pinsky PF, Cheung LC, Castle PE, et al. (2023). Recalibration of a Deep Learning Model for Low-Dose Computed Tomographic Images to Inform Lung Cancer Screening Intervals. JAMA Netw Open. 6(3): e233273. https://doi.org/10.1001/jamanetworkopen.2023.3273 PMID: 36929398
108. Lawrence P, Chabane M, Abrouk L, Thiesson A, Berthe D, Diarra AB, et al. (2023). First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali. Diagnostics (Basel). 13(3): 375. https://doi.org/10.3390/diagnostics13030375 PMID: 36766478
109. Lee R, Robbins HA (2023). PATHFINDER: another step on the uncharted path to multicancer screening. Lancet. 402(10409): 1213-1215. https://doi.org/10.1016/S0140-6736(23)02050-0 PMID: 37805199
110. Leyden GM, Greenwood MP, Gaborieau V, Han Y, Amos CI, Brennan P, et al. (2023). Disentangling the aetiological pathways between body mass index and site-specific cancer risk using tissue-partitioned Mendelian randomisation. Br J Cancer. 128(4): 618-625. https://doi.org/10.1038/s41416-022-02060-6 PMID: 36434155
111. Li M, Park JY, Sheikh M, Kayamba V, Rumgay H, Jenab M, et al. (2023). Population-based investigation of common and deviating patterns of gastric cancer and oesophageal cancer incidence across populations and time. Gut. 72(5): 846-854. https://doi.org/10.1136/gutjnl-2022-328233 PMID: 36241389
112. Lindstrom S, Wang L, Feng H, Majumdar A, Huo S, Macdonald J, et al. (2023). Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. J Natl Cancer Inst. 115(6): 712-732. https://doi.org/10.1093/jnci/djad043 PMID: 36929942
113. Loding S, Andersson U, Kaaks R, Schulze MB, Pala V, Urbarova I, et al. (2023). Altered plasma metabolite levels can be detected years before a glioma diagnosis. JCI Insight. 8(19): e171225. https://doi.org/10.1172/jci.insight.171225 PMID: 37651185
114. Lung Cancer Cohort C (2023). The blood proteome of imminent lung cancer diagnosis. Nat Commun. 14(1): 3042. https://doi.org/10.1038/s41467-023-37979-8 PMID: 37264016
115. Luyapan J, Bossé Y, Li Z, Xiao X, Rosenberger A, Hung RJ, et al. (2023). Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk. Hum Mol Genet. 32(18): 2842-2855. https://doi.org/10.1093/hmg/ddad095 PMID: 37471639
116. M Filho A, Turner MC, Warnakulasuriya S, Richardson DB, Hosseini B, Kamangar F, et al. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. Eur J Epidemiol. 38(4): 373-389. https://doi.org/10.1007/s10654-023-00969-7 PMID: 36773182
117. Malarstig A, Grassmann F, Dahl L, Dimitriou M, McLeod D, Gabrielson M, et al. (2023). Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation. Nat Commun. 14(1): 7680. https://doi.org/10.1038/s41467-023-43485-8 PMID: 37996402
118. Mangiante L, Alcala N, Sexton-Oates A, Di Genova A, Gonzalez-Perez A, Khandekar A, et al. (2023). Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity. Nat Genet. 55(4): 607-618. https://doi.org/10.1038/s41588-023-01321-1 PMID: 36928603
119. Midttun O, Ulvik A, Meyer K, Zahed H, Giles GG, Manjer J, et al. (2023). A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the Lung Cancer Cohort Consortium. Sci Rep. 13(1): 1011. https://doi.org/10.1038/s41598-023-28135-9 PMID: 36653422
120. Nalini M, Poustchi H, Roshandel G, Kamangar F, Khoshnia M, Gharavi A, et al. (2023). Association Between Incident Type 2 Diabetes and Opium Use: Mediation by Body Mass and Adiposity. Am J Epidemiol. 192(12): 2050-2062. https://doi.org/10.1093/aje/kwad166 PMID: 37552966
121. Namaki M, Hashemian M, Arj A, Poustchi H, Roshandel G, Loghman AH, et al. (2023). Diet Quality and Subsequent Incidence of Upper Gastrointestinal Cancers: Results from the Golestan Cohort Study. Arch Iran Med. 26(9): 489-498. https://doi.org/10.34172/aim.2023.74 PMID: 38310404
122. Nemati S, Mohebbi E, Toorang F, Hadji M, Hosseini B, Saeedi E, et al. (2023). Population attributable proportion and number of cancer cases attributed to potentially modifiable risk factors in Iran in 2020. Int J Cancer. 153(10): 1758-1765. https://doi.org/10.1002/ijc.34659 PMID: 37548110
123. Nemati S, Naji P, Abdi S, Lotfi F, Saeedi E, Mehravar SA, et al. (2023). National and Regional Fraction of Cancer Incidence and Death Attributable to Current Tobacco and Water-Pipe Smoking in the Eastern Mediterranean Countries in 2020. Nicotine Tob Res. 25(1): 12-18. https://doi.org/10.1093/ntr/ntac179 PMID: 35895382
124. Nemati S, Saeedi E, Lotfi F, Nahvijou A, Pirnejad H, Cheraghi M, et al. (2023). Regional disparities in cancer survival in Iran: Insight from a National Surveillance of Cancer Survival in Iran (IRANCANSURV). Cancer Epidemiol. 85: 102378. https://doi.org/10.1016/j.canep.2023.102378 PMID: 37229955
125. Nost TH, Skogholt AH, Urbarova I, Mjelle R, Paulsen EE, Donnem T, et al. (2023). Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer. Mol Oncol. 17(2): 312-327. https://doi.org/10.1002/1878-0261.13336 PMID: 36337027
126. Papadimitriou N, Bull CJ, Jenab M, Hughes DJ, Bell JA, Sanderson E, et al. (2023). Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study. BMC Med. 21(1): 5. https://doi.org/10.1186/s12916-022-02702-9 PMID: 36600297
127. Perim Galvao De Podesta O, Salaroli LB, Cattafesta M, Peres SV, De Podesta JRV, von Zeidler SLV, et al. (2023). Changes in Body Mass Index Are Associated with Squamous Cell Carcinomas of Oral Cavity, Oropharynx and Larynx: A Case-Control Study in Brazil. Nutr Cancer. 75(2): 599-609. https://doi.org/10.1080/01635581.2022.2143535 PMID: 36426640
128. Rashidian H, Hadji M, Gholipour M, Naghibzadeh-Tahami A, Marzban M, Mohebbi E, et al. (2023). Opium use and risk of lung cancer: A multicenter case-control study in Iran. Int J Cancer. 152(2): 203-213. https://doi.org/10.1002/ijc.34244 PMID: 36043555
129. Robbins HA, Alcala K, Moez EK, Guida F, Thomas S, Zahed H, et al. (2023). Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program. Ann Epidemiol. 77: 1-12. https://doi.org/10.1016/j.annepidem.2022.10.014 PMID: 36404465
130. Rogers M, Gill D, Ahlqvist E, Robinson T, Mariosa D, Johansson M, et al. (2023). Genetically proxied impaired GIPR signaling and risk of 6 cancers. iScience. 26(6): 106848. https://doi.org/10.1016/j.isci.2023.106848 PMID: 37250804
131. Sheikh M, Brennan P, Mariosa D, Robbins HA (2023). Opioid medications: an emerging cancer risk factor? Br J Anaesth. 130(3): e401-e403. https://doi.org/10.1016/j.bja.2022.12.007 PMID: 36682937
132. Sheikh M, Mukeriya A, Zahed H, Feng X, Robbins HA, Shangina O, et al. (2023). Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort Study. J Clin Oncol. 41(15): 2747-2755. https://doi.org/10.1200/JCO.22.02472 PMID: 36989465
133. Sheikh M, Roshandel G, McCormack V, Malekzadeh R (2023). Current Status and Future Prospects for Esophageal Cancer. Cancers (Basel). 15(3). https://doi.org/10.3390/cancers15030765 PMID: 36765722
134. Sheikh M, Virani S, Robbins HA, Foretova L, Holcatova I, Janout V, et al. (2023). Survival and prognostic factors of early-stage non-small cell lung cancer in Central and Eastern Europe: A prospective cohort study. Cancer Med. 12(9): 10563-10574. https://doi.org/10.1002/cam4.5791 PMID: 36952375
135. Shi J, Shiraishi K, Choi J, Matsuo K, Chen TY, Dai J, et al. (2023). Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. Nat Commun. 14(1): 3043. https://doi.org/10.1038/s41467-023-38196-z PMID: 37236969
136. Soroush A, Malekzadeh R, Roshandel G, Khoshnia M, Poustchi H, Kamangar F, et al. (2023). Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study. Int J Cancer. 152(6): 1137-1149. https://doi.org/10.1002/ijc.34313 PMID: 36214797
137. Sugier PE, Lucotte EA, Domenighetti C, Law MH, Iles MM, Brown K, et al. (2023). Investigation of Shared Genetic Risk Factors Between Parkinson’s Disease and Cancers. Mov Disord. 38(4): 604-615. https://doi.org/10.1002/mds.29337 PMID: 36788297
138. Takata Y, Yang JJ, Yu D, Smith-Warner SA, Blot WJ, White E, et al. (2023). Calcium Intake and Lung Cancer Risk: A Pooled Analysis of 12 Prospective Cohort Studies. J Nutr. 153(7): 2051-2060. https://doi.org/10.1016/j.tjnut.2023.03.011 PMID: 36907443
139. Vasudev NS, Scelo G, Glennon KI, Wilson M, Letourneau L, Eveleigh R, et al. (2023). Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma. Clin Cancer Res. 29(7): 1220-1231. https://doi.org/10.1158/1078-0432.CCR-22-1936 PMID: 36815791
140. Wu WY, Haider Z, Feng X, Heath AK, Tjonneland A, Agudo A, et al. (2023). Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts. Int J Cancer. 152(9): 2002-2010. https://doi.org/10.1002/ijc.34340 PMID: 36305647
141. Yammine SG, Huybrechts I, Biessy C, Dossus L, Panico S, Sanchez MJ, et al. (2023). Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. BMC Cancer. 23(1): 159. https://doi.org/10.1186/s12885-023-10611-0 PMID: 36797668
142. Zvereva M, Hosen MI, Forey N, Sheikh M, Kannengiesser C, Ba I, et al. (2023). Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-invasive Diagnosis of Urothelial Cancer. Methods Mol Biol. 2684: 213-228. https://doi.org/10.1007/978-1-0716-3291-8_13 PMID: 37410237
143. Alcala K, Mariosa D, Smith-Byrne K, Nasrollahzadeh Nesheli D, Carreras-Torres R, Ardanaz Aicua E, et al. (2022). The relationship between blood pressure and risk of renal cell carcinoma. Int J Epidemiol. 51(4): 1317-1327. https://doi.org/10.1093/ije/dyac042 PMID: 35312764
144. Alcala N, Rosenberg NA (2022). Mathematical constraints on F(ST): multiallelic markers in arbitrarily many populations. Philos Trans R Soc Lond B Biol Sci. 377(1852): 20200414. https://doi.org/10.1098/rstb.2020.0414 PMID: 35430885
145. Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. (2022). Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 36(12): 2835-2844. https://doi.org/10.1038/s41375-022-01711-0 PMID: 36273105
146. Bouras E, Karhunen V, Gill D, Huang J, Haycock PC, Gunter MJ, et al. (2022). Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis. BMC Med. 20(1): 3. https://doi.org/10.1186/s12916-021-02193-0 PMID: 35012533
147. Bouvard V, Nethan ST, Singh D, Warnakulasuriya S, Mehrotra R, Chaturvedi AK, et al. (2022). IARC Perspective on Oral Cancer Prevention. N Engl J Med. 387(21): 1999-2005. https://doi.org/10.1056/NEJMsr2210097 PMID: 36378601
148. Breeur M, Ferrari P, Dossus L, Jenab M, Johansson M, Rinaldi S, et al. (2022). Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 20(1): 351. https://doi.org/10.1186/s12916-022-02553-4 PMID: 36258205
149. Brennan P, Davey-Smith G (2022). Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed. J Natl Cancer Inst. 114(3): 353-360. https://doi.org/10.1093/jnci/djab204 PMID: 34743211
150. Bukavina L, Bensalah K, Bray F, Carlo M, Challacombe B, Karam JA, et al. (2022). Epidemiology of Renal Cell Carcinoma: 2022 Update. Eur Urol. 82(5): 529-542. https://doi.org/10.1016/j.eururo.2022.08.019 PMID: 36100483
151. Byun J, Han Y, Li Y, Xia J, Long E, Choi J, et al. (2022). Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer. Nat Genet. 54(8): 1167-1177. https://doi.org/10.1038/s41588-022-01115-x PMID: 35915169
152. Cai J, Chen H, Lu M, Zhang Y, Lu B, Luo C, et al. (2022). Association between Temporal Glycemic Change and Risk of Pancreatic Cancer in Men: A Prospective Cohort Study. Cancers (Basel). 14(14): 12. https://doi.org/10.3390/cancers14143403 PMID: 35884465
153. Claeys L, De Saeger S, Scelo G, Biessy C, Casagrande C, Nicolas G, et al. (2022). Mycotoxin Exposure and Renal Cell Carcinoma Risk: An Association Study in the EPIC European Cohort. Nutrients. 14(17): 3581. https://doi.org/10.3390/nu14173581 PMID: 36079840
154. Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, et al. (2022). Biomarkers of the transsulfuration pathway and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Int J Cancer. 151(5): 708-716. https://doi.org/10.1002/ijc.34009 PMID: 35366005
155. Collatuzzo G, Etemadi A, Sotoudeh M, Nikmanesh A, Poustchi H, Khoshnia M, et al. (2022). Meat consumption and risk of esophageal and gastric cancer in the Golestan Cohort Study, Iran. Int J Cancer. 151(7): 1005-1012. https://doi.org/10.1002/ijc.34056 PMID: 35489023
156. Di Genova A, Mangiante L, Sexton-Oates A, Voegele C, Fernandez-Cuesta L, Alcala N, et al. (2022). A molecular phenotypic map of malignant pleural mesothelioma. Gigascience. 12: 13. https://doi.org/10.1093/gigascience/giac128 PMID: 36705549
157. Dianatinasab M, Wesselius A, Salehi-Abargouei A, Yu EYW, Fararouei M, Brinkman M, et al. (2022). Dietary fats and their sources in association with the risk of bladder cancer: A pooled analysis of 11 prospective cohort studies. Int J Cancer. 151(1): 44-55. https://doi.org/10.1002/ijc.33970 PMID: 35182086
158. Ecke TH, Le Calvez-Kelm F, Otto T (2022). Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision. Int J Mol Sci. 23(10): 5620. https://doi.org/10.3390/ijms23105620 PMID: 35628431
159. Emerson MA, Farquhar DR, Lenze NR, Sheth S, Mazul AL, Zanation AM, et al. (2022). Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients. Head Neck. 44(4): 823-834. https://doi.org/10.1002/hed.26977 PMID: 35044015
160. Etemadi A, Hariri S, Hassanian-Moghaddam H, Poustchi H, Roshandel G, Shayanrad A, et al. (2022). Lead poisoning among asymptomatic individuals with a long-term history of opiate use in Golestan Cohort Study. Int J Drug Policy. 104: 103695. https://doi.org/10.1016/j.drugpo.2022.103695 PMID: 35472727
161. Feng XS, Zahed H, Robbins HA (2022). Editorial Comment. J Urol. 207(2): 332. https://doi.org/10.1097/JU.0000000000002249.01 PMID: 34781695
162. Gabriel AAG, Atkins JR, Penha RCC, Smith-Byrne K, Gaborieau V, Voegele C, et al. (2022). Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden. J Natl Cancer Inst. 114(8): 1159-1166. https://doi.org/10.1093/jnci/djac087 PMID: 35511172
163. Galati L, Combes JD, Le Calvez-Kelm F, McKay-Chopin S, Forey N, Ratel M, et al. (2022). Detection of Circulating HPV16 DNA as a Biomarker for Cervical Cancer by a Bead-Based HPV Genotyping Assay. Microbiol Spectr. 10(2): e0148021. https://doi.org/10.1128/spectrum.01480-21 PMID: 35225653
164. Gislon LC, Curado MP, Lopez RVM, de Oliveira JC, Vasconcelos de Podesta JR, Ventorin von Zeidler S, et al. (2022). Risk factors associated with head and neck cancer in former smokers: A Brazilian multicentric study. Cancer Epidemiol. 78: 102143. https://doi.org/10.1016/j.canep.2022.102143 PMID: 35378425
165. Gormley M, Dudding T, Kachuri L, Burrows K, Chong AHW, Martin RM, et al. (2022). Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization. BMC Med. 20(1): 40. https://doi.org/10.1186/s12916-022-02233-3 PMID: 35094705
166. Guida F, Kidman R, Ferlay J, Schuz J, Soerjomataram I, Kithaka B, et al. (2022). Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 28(12): 2563-2572. https://doi.org/10.1038/s41591-022-02109-2 PMID: 36404355
167. Hadji M, Rashidian H, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Mohebbi E, et al. (2022). Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran. Int J Epidemiol. 51(3): 830-838. https://doi.org/10.1093/ije/dyac031 PMID: 35244716
168. Hasanau T, Pisarev E, Kisil O, Nonoguchi N, Le Calvez-Kelm F, Zvereva M (2022). Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances. Biomedicines. 10(3). https://doi.org/10.3390/biomedicines10030728 PMID: 35327529
169. Hejazi E, Emamat H, Sharafkhah M, Saidpour A, Poustchi H, Sepanlou S, et al. (2022). Dietary acid load and mortality from all causes, CVD and cancer: results from the Golestan Cohort Study. Br J Nutr. 128(2): 237-243. https://doi.org/10.1017/S0007114521003135 PMID: 34392847
170. Hemissi I, Boussetta S, Dallali H, Hellal F, Durand G, Voegele C, et al. (2022). Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Mol Biol Rep. 49(2): 1233-1258. https://doi.org/10.1007/s11033-021-06951-4 PMID: 34854013
171. Hemissi I, Boussetta S, Dallali H, Hellal F, Durand G, Voegele C, et al. (2022). Correction to: Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort. Mol Biol Rep. 49(2): 1259. https://doi.org/10.1007/s11033-021-07052-y PMID: 34977990
172. Hong W, Li A, Liu Y, Xiao X, Christiani DC, Hung RJ, et al. (2022). Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors. Cancer Res. 82(2): 199-209. https://doi.org/10.1158/0008-5472.CAN-21-1903 PMID: 34815255
173. Islam SMA, Diaz-Gay M, Wu Y, Barnes M, Vangara R, Bergstrom EN, et al. (2022). Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2(11): None. https://doi.org/10.1016/j.xgen.2022.100179 PMID: 36388765
174. Islam SMA, Díiaz-Gay M, Wu Y, Barnes M, Vangara R, Bergstrom EN, et al. (2022). Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genomics. 2(11): 34.
175. Kolijn PM, Hosnijeh FS, Spath F, Hengeveld PJ, Agathangelidis A, Saleh M, et al. (2022). High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis. Blood. 139(10): 1557-1563. https://doi.org/10.1182/blood.2021012890 PMID: 34662377
176. Li M, Zhang L, Charvat H, Callister ME, Sasieni P, Christodoulou E, et al. (2022). The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials. Int J Cancer. 151(9): 1491-1501. https://doi.org/10.1002/ijc.34167 PMID: 35809038
177. Li Y, Xiao X, Li J, Byun J, Cheng C, Bosse Y, et al. (2022). Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk. Hum Mol Genet. 31(16): 2831-2843. https://doi.org/10.1093/hmg/ddac030 PMID: 35138370
178. Mariosa D, Smith-Byrne K, Richardson TG, Ferrari P, Gunter MJ, Papadimitriou N, et al. (2022). Body Size at Different Ages and Risk of 6 Cancers: A Mendelian Randomization and Prospective Cohort Study. J Natl Cancer Inst. 114(9): 1296-1300. https://doi.org/10.1093/jnci/djac061 PMID: 35438160
179. Masukume G, Mmbaga BT, Dzamalala CP, Mlombe YB, Finch P, Nyakunga-Maro G, et al. (2022). A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies. Br J Cancer. 127(6): 1106-1115. https://doi.org/10.1038/s41416-022-01890-8 PMID: 35768549
180. Mc Leer A, Foll M, Brevet M, Antoine M, Novello S, Mondet J, et al. (2022). Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers. Lung Cancer. 167: 98-106. https://doi.org/10.1016/j.lungcan.2022.01.008 PMID: 35183375
181. Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-Maro G, Finch P, et al. (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. https://doi.org/10.1016/S2214-109X(21)00506-4 PMID: 34921758
182. Mobuchon L, Derrien AC, Houy A, Verrier T, Pierron G, Cassoux N, et al. (2022). Different Pigmentation Risk Loci for High-Risk Monosomy 3 and Low-Risk Disomy 3 Uveal Melanomas. J Natl Cancer Inst. 114(2): 302-309. https://doi.org/10.1093/jnci/djab167 PMID: 34424336
183. Moonen L, Mangiante L, Leunissen DJG, Lap LMV, Gabriel A, Hillen LM, et al. (2022). Differential Orthopedia Homeobox expression in pulmonary carcinoids is associated with changes in DNA methylation. Int J Cancer. 150(12): 1987-1997. https://doi.org/10.1002/ijc.33939 PMID: 35076935
184. Morrison ML, Alcala N, Rosenberg NA (2022). FSTruct: An F(ST) -based tool for measuring ancestry variation in inference of population structure. Mol Ecol Resour. 22(7): 2614-2626. https://doi.org/10.1111/1755-0998.13647 PMID: 35596736
185. Mountzias A, Hultdin J, Hlodan J, Kroger Dahlin BI, Johansson M, Ljungberg B (2022). Inflammatory response markers and survival prediction in patients with renal cell carcinoma. Scand J Urol. 56(1): 47-52. https://doi.org/10.1080/21681805.2021.1983016 PMID: 34586034
186. Nomburg J, Bullman S, Nasrollahzadeh D, Collisson EA, Abedi-Ardekani B, Akoko LO, et al. (2022). An international report on bacterial communities in esophageal squamous cell carcinoma. Int J Cancer. 151(11): 1947-1959. https://doi.org/10.1002/ijc.34212 PMID: 35837755
187. Pakmanesh H, Anvari O, Forey N, Weiderpass E, Malekpourafshar R, Iranpour M, et al. (2022). TERT Promoter Mutations as Simple and Non-Invasive Urinary Biomarkers for the Detection of Urothelial Bladder Cancer in a High-Risk Region. Int J Mol Sci. 23(22): 14319. https://doi.org/10.3390/ijms232214319 PMID: 36430798
188. Pastorino R, Sassano M, Danilo Tiziano F, Giraldi L, Amore R, Arzani D, et al. (2022). Plasma miR-151-3p as a Candidate Diagnostic Biomarker for Head and Neck Cancer: A Cross-sectional Study within the INHANCE Consortium. Cancer Epidemiol Biomarkers Prev. 31(12): 2237-2243. https://doi.org/10.1158/1055-9965.EPI-22-0376 PMID: 36126276
189. Perdomo S, Lopez J, Torres-Ibarguen MZ, Puerto-Jimenez DN, de Vries E (2022). Modelling the Reduction in Cancer Incidence After Variations in the Prevalence of Tobacco Consumption in Colombia in the Period 2016-2050. Cancer Control. 29: 10732748221121390. https://doi.org/10.1177/10732748221121390 PMID: 36415920
190. Petrovic D, Bodinier B, Dagnino S, Whitaker M, Karimi M, Campanella G, et al. (2022). Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking. Eur J Epidemiol. 37(6): 629-640. https://doi.org/10.1007/s10654-022-00877-2 PMID: 35595947
191. Popovic M, Fiano V, Moirano G, Chiusa L, Conway DI, Garzino Demo P, et al. (2022). The Impact of the COVID-19 Pandemic on Head and Neck Cancer Diagnosis in the Piedmont Region, Italy: Interrupted Time-Series Analysis. Front Public Health. 10: 809283. https://doi.org/10.3389/fpubh.2022.809283 PMID: 35265573
192. Porta M, Gasull M, Pumarega J, Kiviranta H, Rantakokko P, Raaschou-Nielsen O, et al. (2022). Plasma concentrations of persistent organic pollutants and pancreatic cancer risk. Int J Epidemiol. 51(2): 479-490. https://doi.org/10.1093/ije/dyab115 PMID: 34259837
193. Robbins HA, Cheung LC, Chaturvedi AK, Baldwin DR, Berg CD, Katki HA (2022). Management of Lung Cancer Screening Results Based on Individual Prediction of Current and Future Lung Cancer Risks. J Thorac Oncol. 17(2): 252-263. https://doi.org/10.1016/j.jtho.2021.10.001 PMID: 34648946
194. Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygard M, Bender N, et al. (2022). Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. J Clin Oncol. 40(31): 3613-3622. https://doi.org/10.1200/JCO.21.01785 PMID: 35700419
195. Robbins HA, Landy R, Ahluwalia JS (2022). Achieving Equity in Lung Cancer Screening for Black Individuals Requires Innovation to Move Beyond “Equal” Guidelines. JAMA Oncol. 8(4): 1-2. https://doi.org/10.1001/jamaoncol.2021.7252 PMID: 35201279
196. Robbins HA, Zahed H, Lebrett MB, Balata H, Johansson M, Sharman A, et al. (2022). Explaining differences in the frequency of lung cancer detection between the National Lung Screening Trial and community-based screening in Manchester, UK. Lung Cancer. 171: 61-64. https://doi.org/10.1016/j.lungcan.2022.07.017 PMID: 35917648
197. Rosenberger A, Muttray N, Hung RJ, Christiani DC, Caporaso NE, Liu G, et al. (2022). Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer. Eur J Med Res. 27(1): 14. https://doi.org/10.1186/s40001-022-00638-7 PMID: 35101137
198. Schmid S, Jiang M, Brown MC, Fares A, Garcia M, Soriano J, et al. (2022). Accounting for EGFR Mutations in Epidemiologic Analyses of Non-Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data. Cancer Epidemiol Biomarkers Prev. 31(3): 679-687. https://doi.org/10.1158/1055-9965.EPI-21-0747 PMID: 35027437
199. Sichero L, Tagliabue M, Mota G, Ferreira S, Nunes RAL, Castaneda CA, et al. (2022). Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status. Head Neck. 44(1): 122-133. https://doi.org/10.1002/hed.26912 PMID: 34726297
200. Simoens C, Gheit T, Ridder R, Gorbaslieva I, Holzinger D, Lucas E, et al. (2022). Accuracy of high-risk HPV DNA PCR, p16((INK4a)) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer. BMC Infect Dis. 22(1): 676. https://doi.org/10.1186/s12879-022-07654-2 PMID: 35933382
201. Simon J, Brenner N, Reich S, Langseth H, Hansen BT, Ursin G, et al. (2022). Nasopharyngeal carcinoma patients from Norway show elevated Epstein-Barr virus IgA and IgG antibodies prior to diagnosis. Cancer Epidemiol. 77: 102117. https://doi.org/10.1016/j.canep.2022.102117 PMID: 35121404
202. Smith-Byrne K, Cerani A, Guida F, Zhou S, Agudo A, Aleksandrova K, et al. (2022). Circulating Isovalerylcarnitine and Lung Cancer Risk: Evidence from Mendelian Randomization and Prediagnostic Blood Measurements. Cancer Epidemiol Biomarkers Prev. 31(10): 1966-1974. https://doi.org/10.1158/1055-9965.EPI-21-1033 PMID: 35839461
203. Tran KB, Lang JJ, Compton K, Xu RX, Acheson AR, Henrikson HJ, et al. (2022). The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 400(10352): 563-591. https://doi.org/10.1016/S0140-6736(22)01438-6 PMID: 35988567
204. Wade KH, Yarmolinsky J, Giovannucci E, Lewis SJ, Millwood IY, Munafo MR, et al. (2022). Applying Mendelian randomization to appraise causality in relationships between nutrition and cancer. Cancer Causes Control. 33(5): 631-652. https://doi.org/10.1007/s10552-022-01562-1 PMID: 35274198
205. Watts EL, Perez-Cornago A, Fensom GK, Smith-Byrne K, Noor U, Andrews CD, et al. (2022). Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortia. Int J Cancer. 151(7): 1033-1046. https://doi.org/10.1002/ijc.34116 PMID: 35579976
206. Yang JJ, Yu D, White E, Lee DH, Blot W, Robien K, et al. (2022). Prediagnosis Leisure-Time Physical Activity and Lung Cancer Survival: A Pooled Analysis of 11 Cohorts. JNCI Cancer Spectr. 6(2): 11. https://doi.org/10.1093/jncics/pkac009 PMID: 35603841
207. Yang W, Liu H, Zhang R, Freedman JA, Han Y, Hung RJ, et al. (2022). Deciphering associations between three RNA splicing-related genetic variants and lung cancer risk. NPJ Precis Oncol. 6(1): 48. https://doi.org/10.1038/s41698-022-00281-9 PMID: 35773316
208. Yao S, Campbell PT, Ugai T, Gierach G, Abubakar M, Adalsteinsson V, et al. (2022). Proceedings of the fifth international Molecular Pathological Epidemiology (MPE) meeting. Cancer Causes Control. 33(8): 1107-1120. https://doi.org/10.1007/s10552-022-01594-7 PMID: 35759080
209. Yarmolinsky J, Amos CI, Hung RJ, Moreno V, Burrows K, Smith-Byrne K, et al. (2022). Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk. Int J Cancer. 151(12): 2155-2160. https://doi.org/10.1002/ijc.34180 PMID: 35747941
210. Zhang R, Shen S, Wei Y, Zhu Y, Li Y, Chen J, et al. (2022). A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians. J Thorac Oncol. 17(8): 974-990. https://doi.org/10.1016/j.jtho.2022.04.011 PMID: 35500836
211. Abedi-Ardekani B, Nasrollahzadeh D, Egevad L, Banks RE, Vasudev N, Holcatova I, et al. (2021). Morphological findings in frozen non-neoplastic kidney tissues of patients with kidney cancer from large-scale multicentric studies on renal cancer. Virchows Arch. 478(6): 1099-1107. https://doi.org/10.1007/s00428-020-02986-3 PMID: 33403511
212. Aredo JV, Luo SJ, Gardner RM, Sanyal N, Choi E, Hickey TP, et al. (2021). Tobacco Smoking and Risk of Second Primary Lung Cancer. J Thorac Oncol. 16(6): 968-979. https://doi.org/10.1016/j.jtho.2021.02.024 PMID: 33722709
213. Baldwin DR, Callister ME, Crosbie PA, O’Dowd EL, Rintoul RC, Robbins HA, et al. (2021). Biomarkers in lung cancer screening: the importance of study design. Eur Respir J. 57(1). https://doi.org/10.1183/13993003.04367-2020 PMID: 33446580
214. Barker J, Smith-Byrne K, Sayers O, Joseph K, Sleeman M, Lasserson D, et al. (2021). Electronic alerts for acute kidney injury across primary and secondary care. BMJ Open Qual. 10(2): 7. https://doi.org/10.1136/bmjoq-2020-000956 PMID: 33972363
215. Baumeister SE, Baurecht H, Nolde M, Alayash Z, Glaser S, Johansson M, et al. (2021). Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study. J Thorac Oncol. 16(7): 1127-1135. https://doi.org/10.1016/j.jtho.2021.03.025 PMID: 33852959
216. Bray MJ, Chen LS, Fox L, Ma Y, Grucza RA, Hartz SM, et al. (2021). Studying the Utility of Using Genetics to Predict Smoking-Related Outcomes in a Population-Based Study and a Selected Cohort. Nicotine Tob Res. 23(12): 2110-2116. https://doi.org/10.1093/ntr/ntab100 PMID: 33991188
217. Byun J, Han Y, Ostrom QT, Edelson J, Walsh KM, Pettit RW, et al. (2021). The Shared Genetic Architectures Between Lung Cancer and Multiple Polygenic Phenotypes in Genome-Wide Association Studies. Cancer Epidemiol Biomarkers Prev. 30(6): 1156-1164. https://doi.org/10.1158/1055-9965.EPI-20-1635 PMID: 33771847
218. Callister MEJ, Sasieni P, Robbins HA (2021). Overdiagnosis in lung cancer screening. Lancet Respir Med. 9(1): 7-9. https://doi.org/10.1016/S2213-2600(20)30553-1 PMID: 33412118
219. Chen H, Majumdar A, Wang L, Kar S, Brown KM, Feng H, et al. (2021). Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. HGG Adv. 2(3): 100041. https://doi.org/10.1016/j.xhgg.2021.100041 PMID: 34355204
220. Christakoudi S, Pagoni P, Ferrari P, Cross AJ, Tzoulaki I, Muller DC, et al. (2021). Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Int J Cancer. 148(7): 1637-1651. https://doi.org/10.1002/ijc.33339 PMID: 33038275
221. Clasen JL, Heath AK, Van Puyvelde H, Huybrechts I, Park JY, Ferrari P, et al. (2021). A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr. 114(1): 338-347. https://doi.org/10.1093/ajcn/nqab045 PMID: 33829249
222. Collaboration NCDRF (2021). Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. Elife. 10. https://doi.org/10.7554/eLife.60060 PMID: 33685583
223. Collaboration NCDRF (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 398(10304): 957-980. https://doi.org/10.1016/S0140-6736(21)01330-1 PMID: 34450083
224. Conway DI, Hovanec J, Ahrens W, Ross A, Holcatova I, Lagiou P, et al. (2021). Occupational socioeconomic risk associations for head and neck cancer in Europe and South America: individual participant data analysis of pooled case-control studies within the INHANCE Consortium. J Epidemiol Community Health. 75(8): 779-787. https://doi.org/10.1136/jech-2020-214913 PMID: 33622804
225. Cree IA, Indave Ruiz BI, Zavadil J, McKay J, Olivier M, Kozlakidis Z, et al. (2021). The International Collaboration for Cancer Classification and Research. Int J Cancer. 148(3): 560-571. https://doi.org/10.1002/ijc.33260 PMID: 32818326
226. Dagnino S, Bodinier B, Guida F, Smith-Byrne K, Petrovic D, Whitaker MD, et al. (2021). Prospective Identification of Elevated Circulating CDCP1 in Patients Years before Onset of Lung Cancer. Cancer Res. 81(13): 3738-3748. https://doi.org/10.1158/0008-5472.CAN-20-3454 PMID: 33574093
227. Dianatinasab M, Wesselius A, de Loeij T, Salehi-Abargouei A, Yu EYW, Fararouei M, et al. (2021). The association between meat and fish consumption and bladder cancer risk: a pooled analysis of 11 cohort studies. Eur J Epidemiol. 36(8): 781-792. https://doi.org/10.1007/s10654-021-00762-4 PMID: 34036467
228. Dimou N, Mori N, Harlid S, Harbs J, Martin RM, Smith-Byrne K, et al. (2021). Circulating Levels of Testosterone, Sex Hormone Binding Globulin and Colorectal Cancer Risk: Observational and Mendelian Randomization Analyses. Cancer Epidemiol Biomarkers Prev. 30(7): 1336-1348. https://doi.org/10.1158/1055-9965.EPI-20-1690 PMID: 33879453
229. Dimou NL, Papadimitriou N, Mariosa D, Johansson M, Brennan P, Peters U, et al. (2021). Circulating adipokine concentrations and risk of five obesity-related cancers: A Mendelian randomization study. Int J Cancer. 148(7): 1625-1636. https://doi.org/10.1002/ijc.33338 PMID: 33038280
230. Fernandez-Cuesta L, Mangiante L, Alcala N, Foll M (2021). Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas. Virchows Arch. 478(1): 73-80. https://doi.org/10.1007/s00428-020-02980-9 PMID: 33411030
231. Ferreiro-Iglesias A, McKay JD, Brenner N, Virani S, Lesseur C, Gaborieau V, et al. (2021). Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat Commun. 12(1): 5945. https://doi.org/10.1038/s41467-021-26151-9 PMID: 34642315
232. Ghasemi-Kebria F, Jafari-Delouie N, Amiriani T, Norouzi A, Abedi-Ardekani B, Nasrollahzadeh D, et al. (2021). Building a Cancer Biobank in a Low-Resource Setting in Northern Iran: the Golestan Cancer Biobank. Arch Iran Med. 24(7): 526-533. https://doi.org/10.34172/aim.2021.75 PMID: 34488317
233. Ginsburg O, Ashton-Prolla P, Cantor A, Mariosa D, Brennan P (2021). The role of genomics in global cancer prevention. Nat Rev Clin Oncol. 18(2): 116-128. https://doi.org/10.1038/s41571-020-0428-5 PMID: 32973296
234. Gonzalez Maldonado S, Hynes LC, Motsch E, Heussel CP, Kauczor HU, Robbins HA, et al. (2021). Validation of multivariable lung cancer risk prediction models for the personalized assignment of optimal screening frequency: a retrospective analysis of data from the German Lung Cancer Screening Intervention Trial (LUSI). Transl Lung Cancer Res. 10(3): 1305-1317. https://doi.org/10.21037/tlcr-20-1173 PMID: 33889511
235. Gormley M, Yarmolinsky J, Dudding T, Burrows K, Martin RM, Thomas S, et al. (2021). Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study. PLoS Genet. 17(4): e1009525. https://doi.org/10.1371/journal.pgen.1009525 PMID: 33886544
236. Guida F, Tan VY, Corbin LJ, Smith-Byrne K, Alcala K, Langenberg C, et al. (2021). The blood metabolome of incident kidney cancer: A case-control study nested within the MetKid consortium. PLoS Med. 18(9): e1003786. https://doi.org/10.1371/journal.pmed.1003786 PMID: 34543281
237. Hadji M, Rashidian H, Marzban M, Gholipour M, Naghibzadeh-Tahami A, Mohebbi E, et al. (2021). The Iranian Study of Opium and Cancer (IROPICAN): Rationale, Design, and Initial Findings. Arch Iran Med. 24(3): 167-176. https://doi.org/10.34172/aim.2021.27 PMID: 33878874
238. Hashemian M, Merat S, Poustchi H, Jafari E, Radmard AR, Kamangar F, et al. (2021). Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study. Am J Gastroenterol. 116(8): 1667-1675. https://doi.org/10.14309/ajg.0000000000001229 PMID: 33767101
239. Hubert JN, Suybeng V, Vallee M, Delhomme TM, Maubec E, Boland A, et al. (2021). The PI3K/mTOR Pathway Is Targeted by Rare Germline Variants in Patients with Both Melanoma and Renal Cell Carcinoma. Cancers (Basel). 13(9). https://doi.org/10.3390/cancers13092243 PMID: 34067022
240. Hung RJ, Warkentin MT, Brhane Y, Chatterjee N, Christiani DC, Landi MT, et al. (2021). Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model. Cancer Res. 81(6): 1607-1615. https://doi.org/10.1158/0008-5472.CAN-20-1237 PMID: 33472890
241. Julian-Serrano S, Yuan F, Wheeler W, Benyamin B, Machiela MJ, Arslan AA, et al. (2021). Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. 114(4): 1408-1417. https://doi.org/10.1093/ajcn/nqab217 PMID: 34258619
242. Kliemann N, Viallon V, Murphy N, Beeken RJ, Rothwell JA, Rinaldi S, et al. (2021). Metabolic signatures of greater body size and their associations with risk of colorectal and endometrial cancers in the European Prospective Investigation into Cancer and Nutrition. BMC Med. 19(1): 101. https://doi.org/10.1186/s12916-021-01970-1 PMID: 33926456
243. Landy R, Young CD, Skarzynski M, Cheung LC, Berg CD, Rivera MP, et al. (2021). Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines. J Natl Cancer Inst. 113(11): 1590-1594. https://doi.org/10.1093/jnci/djaa211 PMID: 33399825
244. Laskar R, Ferreiro-Iglesias A, Bishop DT, Iles MM, Kanetsky PA, Armstrong BK, et al. (2021). Risk factors for melanoma by anatomical site: an evaluation of aetiological heterogeneity. Br J Dermatol. 184(6): 1085-1093. https://doi.org/10.1111/bjd.19705 PMID: 33270213
245. Laskar RS, Li P, Ecsedi S, Abedi-Ardekani B, Durand G, Robinot N, et al. (2021). Sexual dimorphism in cancer: insights from transcriptional signatures in kidney tissue and renal cell carcinoma. Hum Mol Genet. 30(5): 343-355. https://doi.org/10.1093/hmg/ddab031 PMID: 33527138
246. Lesseur C, Ferreiro-Iglesias A, McKay JD, Bosse Y, Johansson M, Gaborieau V, et al. (2021). Genome-wide association meta-analysis identifies pleiotropic risk loci for aerodigestive squamous cell cancers. PLoS Genet. 17(3): e1009254. https://doi.org/10.1371/journal.pgen.1009254 PMID: 33667223
247. Liu Y, Xia J, McKay J, Tsavachidis S, Xiao X, Spitz MR, et al. (2021). Rare deleterious germline variants and risk of lung cancer. NPJ Precis Oncol. 5(1): 12. https://doi.org/10.1038/s41698-021-00146-7 PMID: 33594163
248. Liu Z, Derkach A, Yu KJ, Yeager M, Chang YS, Chen CJ, et al. (2021). Patterns of Human Leukocyte Antigen Class I and Class II Associations and Cancer. Cancer Res. 81(4): 1148-1152. https://doi.org/10.1158/0008-5472.CAN-20-2292 PMID: 33272927
249. Loftfield E, Stepien M, Viallon V, Trijsburg L, Rothwell JA, Robinot N, et al. (2021). Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality. J Natl Cancer Inst. 113(11): 1542-1550. https://doi.org/10.1093/jnci/djab078 PMID: 34010397
250. Lopez de Maturana E, Rodriguez JA, Alonso L, Lao O, Molina-Montes E, Martin-Antoniano IA, et al. (2021). A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer. Genome Med. 13(1): 15. https://doi.org/10.1186/s13073-020-00816-4 PMID: 33517887
251. Martinez-Gregorio H, Rojas-Jimenez E, Mejia-Gomez JC, Diaz-Velasquez C, Quezada-Urban R, Vallejo-Lecuona F, et al. (2021). The Evolution of Clinically Aggressive Triple-Negative Breast Cancer Shows a Large Mutational Diversity and Early Metastasis to Lymph Nodes. Cancers (Basel). 13(20). https://doi.org/10.3390/cancers13205091 PMID: 34680239
252. Middleton DRS, Mmbaga BT, O’Donovan M, Abedi-Ardekani B, Debiram-Beecham I, Nyakunga-Maro G, et al. (2021). Minimally invasive esophageal sponge cytology sampling is feasible in a Tanzanian community setting. Int J Cancer. 148(5): 1208-1218. https://doi.org/10.1002/ijc.33366 PMID: 33128785
253. Miranda-Filho A, Charvat H, Bray F, Migowski A, Cheung LC, Vaccarella S, et al. (2021). A modeling analysis to compare eligibility strategies for lung cancer screening in Brazil. EClinicalMedicine. 42: 101176. https://doi.org/10.1016/j.eclinm.2021.101176 PMID: 34765952
254. Mmbaga BT, Mwasamwaja A, Mushi G, Mremi A, Nyakunga G, Kiwelu I, et al. (2021). Missing and decayed teeth, oral hygiene and dental staining in relation to esophageal cancer risk: ESCCAPE case-control study in Kilimanjaro, Tanzania. Int J Cancer. 148(10): 2416-2428. https://doi.org/10.1002/ijc.33433 PMID: 33320959
255. Mocci E, Kundu P, Wheeler W, Arslan AA, Beane-Freeman LE, Bracci PM, et al. (2021). Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Cancer Res. 81(11): 3134-3143. https://doi.org/10.1158/0008-5472.CAN-20-3267 PMID: 33574088
256. Mohebbi E, Hadji M, Rashidian H, Rezaianzadeh A, Marzban M, Haghdoost AA, et al. (2021). Opium use and the risk of head and neck squamous cell carcinoma. Int J Cancer. 148(5): 1066-1076. https://doi.org/10.1002/ijc.33289 PMID: 32895947
257. Moody S, Senkin S, Islam SMA, Wang J, Nasrollahzadeh D, Cortez Cardoso Penha R, et al. (2021). Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet. 53(11): 1553-1563. https://doi.org/10.1038/s41588-021-00928-6 PMID: 34663923
258. Moore A, Machiela MJ, Machado M, Wang SS, Kane E, Slager SL, et al. (2021). Genome-wide homozygosity and risk of four non-Hodgkin lymphoma subtypes. J Transl Genet Genom. 5: 200-217. https://doi.org/10.20517/jtgg.2021.08 PMID: 34622145
259. Mullins N, Forstner AJ, O’Connell KS, Coombes B, Coleman JRI, Qiao Z, et al. (2021). Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. Nat Genet. 53(6): 817-829. https://doi.org/10.1038/s41588-021-00857-4 PMID: 34002096
260. Nalini M, Khoshnia M, Kamangar F, Sharafkhah M, Poustchi H, Pourshams A, et al. (2021). Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study. Int J Epidemiol. 50(1): 314-324. https://doi.org/10.1093/ije/dyaa126 PMID: 32810213
261. Nalini M, Khoshnia M, Kamangar F, Sharafkhah M, Poustchi H, Pourshams A, et al. (2021). Corrigendum to: Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study. Int J Epidemiol. 50(1): 353. https://doi.org/10.1093/ije/dyaa268 PMID: 33367601
262. Nalini M, Shakeri R, Poustchi H, Pourshams A, Etemadi A, Islami F, et al. (2021). Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study. Eur J Prev Cardiol. 28(1): 98-106. https://doi.org/10.1093/eurjpc/zwaa006 PMID: 33624066
263. Nasrollahzadeh D, Roshandel G, Delhomme TM, Avogbe PH, Foll M, Saidi F, et al. (2021). TP53 Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation. Int J Mol Sci. 22(11). https://doi.org/10.3390/ijms22115627 PMID: 34073316
264. Nazarzadeh M, Bidel Z, Canoy D, Copland E, Wamil M, Majert J, et al. (2021). Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis. Lancet. 398(10313): 1803-1810. https://doi.org/10.1016/S0140-6736(21)01920-6 PMID: 34774144
265. Nost TH, Alcala K, Urbarova I, Byrne KS, Guida F, Sandanger TM, et al. (2021). Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 36(8): 841-848. https://doi.org/10.1007/s10654-021-00752-6 PMID: 34036468
266. Pettit RW, Byun J, Han Y, Ostrom QT, Edelson J, Walsh KM, et al. (2021). The shared genetic architecture between epidemiological and behavioral traits with lung cancer. Sci Rep. 11(1): 17559. https://doi.org/10.1038/s41598-021-96685-x PMID: 34475455
267. Purdue MP, Rhee J, Moore L, Gao X, Sun X, Kirk E, et al. (2021). Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma. Int J Cancer. 149(7): 1448-1454. https://doi.org/10.1002/ijc.33701 PMID: 34058014
268. Qin N, Li Y, Wang C, Zhu M, Dai J, Hong T, et al. (2021). Comprehensive functional annotation of susceptibility variants identifies genetic heterogeneity between lung adenocarcinoma and squamous cell carcinoma. Front Med. 15(2): 275-291. https://doi.org/10.1007/s11684-020-0779-4 PMID: 32889700
269. Ramakrishnan R, Doherty A, Smith-Byrne K, Rahimi K, Bennett D, Woodward M, et al. (2021). Accelerometer measured physical activity and the incidence of cardiovascular disease: Evidence from the UK Biobank cohort study. PLoS Med. 18(1): e1003487. https://doi.org/10.1371/journal.pmed.1003487 PMID: 33434193
270. Riscal R, Bull CJ, Mesaros C, Finan JM, Carens M, Ho ES, et al. (2021). Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma. Cancer Discov. 11(12): 3106-3125. https://doi.org/10.1158/2159-8290.CD-21-0211 PMID: 34244212
271. Robbins HA, Alcala K, Swerdlow AJ, Schoemaker MJ, Wareham N, Travis RC, et al. (2021). Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom. Br J Cancer. 124(12): 2026-2034. https://doi.org/10.1038/s41416-021-01278-0 PMID: 33846525
272. Rostron BL, Wang J, Etemadi A, Thakur S, Chang JT, Bhandari D, et al. (2021). Associations between Biomarkers of Exposure and Lung Cancer Risk among Exclusive Cigarette Smokers in the Golestan Cohort Study. Int J Environ Res Public Health. 18(14). https://doi.org/10.3390/ijerph18147349 PMID: 34299799
273. Saberi Hosnijeh F, Casabonne D, Nieters A, Solans M, Naudin S, Ferrari P, et al. (2021). Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis. Int J Cancer. 148(9): 2115-2128. https://doi.org/10.1002/ijc.33369 PMID: 33128820
274. Senkin S (2021). MSA: reproducible mutational signature attribution with confidence based on simulations. BMC Bioinformatics. 22(1): 540. https://doi.org/10.1186/s12859-021-04450-8 PMID: 34736398
275. Seyed Khoei N, Carreras-Torres R, Murphy N, Gunter MJ, Brennan P, Smith-Byrne K, et al. (2021). Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study. Cells. 10(2). https://doi.org/10.3390/cells10020394 PMID: 33671849
276. Sheikh M, Mukeriya A, Shangina O, Brennan P, Zaridze D (2021). Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality : A Prospective Cohort Study. Ann Intern Med. 174(9): 1232-1239. https://doi.org/10.7326/M21-0252 PMID: 34310171
277. Sheth S, Farquhar DR, Lenze NR, Mazul A, Brennan P, Anantharaman D, et al. (2021). Decreased overall survival in black patients with HPV-associated oropharyngeal cancer. Am J Otolaryngol. 42(1): 102780. https://doi.org/10.1016/j.amjoto.2020.102780 PMID: 33152576
278. Simoens C, Gorbaslieva I, Gheit T, Holzinger D, Lucas E, Ridder R, et al. (2021). HPV DNA genotyping, HPV E6*I mRNA detection, and p16(INK4a)/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study. Cancer Epidemiol. 72: 101925. https://doi.org/10.1016/j.canep.2021.101925 PMID: 33839457
279. Singleton RK, Heath AK, Clasen JL, Scelo G, Johansson M, Calvez-Kelm FL, et al. (2021). Risk Prediction for Renal Cell Carcinoma: Results from the European Prospective Investigation into Cancer and Nutrition (EPIC) Prospective Cohort Study. Cancer Epidemiol Biomarkers Prev. 30(3): 507-512. https://doi.org/10.1158/1055-9965.EPI-20-1438 PMID: 33335022
280. Sklias A, Halaburkova A, Vanzan L, Jimenez NF, Cuenin C, Bouaoun L, et al. (2021). Epigenetic remodelling of enhancers in response to estrogen deprivation and re-stimulation. Nucleic Acids Res. 49(17): 9738-9754. https://doi.org/10.1093/nar/gkab697 PMID: 34403459
281. Sun R, Xu M, Li X, Gaynor S, Zhou H, Li Z, et al. (2021). Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. Genet Epidemiol. 45(1): 99-114. https://doi.org/10.1002/gepi.22358 PMID: 32924180
282. Sun YQ, Richmond RC, Suderman M, Min JL, Battram T, Flatberg A, et al. (2021). Assessing the role of genome-wide DNA methylation between smoking and risk of lung cancer using repeated measurements: the HUNT study. Int J Epidemiol. 50(5): 1482-1497. https://doi.org/10.1093/ije/dyab044 PMID: 33729499
283. Talukdar FR, Soares Lima SC, Khoueiry R, Laskar RS, Cuenin C, Sorroche BP, et al. (2021). Genome-Wide DNA Methylation Profiling of Esophageal Squamous Cell Carcinoma from Global High-Incidence Regions Identifies Crucial Genes and Potential Cancer Markers. Cancer Res. 81(10): 2612-2624. https://doi.org/10.1158/0008-5472.CAN-20-3445 PMID: 33741694
284. Viallon V, His M, Rinaldi S, Breeur M, Gicquiau A, Hemon B, et al. (2021). A New Pipeline for the Normalization and Pooling of Metabolomics Data. Metabolites. 11(9). https://doi.org/10.3390/metabo11090631 PMID: 34564446
285. Virani S, Baiocchi G, Bowtell D, Cabasag CJ, Cho KR, Fortner RT, et al. (2021). Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research. Carcinogenesis. 42(6): 785-793. https://doi.org/10.1093/carcin/bgab043 PMID: 34037709
286. Waller RG, Klein RJ, Vijai J, McKay JD, Clay-Gilmour A, Wei X, et al. (2021). Sequencing at lymphoid neoplasm susceptibility loci maps six myeloma risk genes. Hum Mol Genet. 30(12): 1142-1153. https://doi.org/10.1093/hmg/ddab066 PMID: 33751038
287. Walmsley R, Chan S, Smith-Byrne K, Ramakrishnan R, Woodward M, Rahimi K, et al. (2021). Reallocation of time between device-measured movement behaviours and risk of incident cardiovascular disease. Br J Sports Med. 56(18): 1008-1017. https://doi.org/10.1136/bjsports-2021-104050 PMID: 34489241
288. Watts EL, Fensom GK, Smith Byrne K, Perez-Cornago A, Allen NE, Knuppel A, et al. (2021). Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200 000 men in UK Biobank. Int J Cancer. 148(9): 2274-2288. https://doi.org/10.1002/ijc.33416 PMID: 33252839
289. Yano Y, Abnet CC, Poustchi H, Roshandel G, Pourshams A, Islami F, et al. (2021). Oral Health and Risk of Upper Gastrointestinal Cancers in a Large Prospective Study from a High-risk Region: Golestan Cohort Study. Cancer Prev Res (Phila). 14(7): 709-718. https://doi.org/10.1158/1940-6207.CAPR-20-0577 PMID: 33731409
290. Yu EY, Wesselius A, Mehrkanoon S, Goosens M, Brinkman M, van den Brandt P, et al. (2021). Vegetable intake and the risk of bladder cancer in the BLadder Cancer Epidemiology and Nutritional Determinants (BLEND) international study. BMC Med. 19(1): 56. https://doi.org/10.1186/s12916-021-01931-8 PMID: 33685459
291. Zahed H, Johansson M, Ueland PM, Midttun O, Milne RL, Giles GG, et al. (2021). Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults. Sci Rep. 11(1): 13805. https://doi.org/10.1038/s41598-021-93214-8 PMID: 34226613
292. Zhou W, Liu G, Hung RJ, Haycock PC, Aldrich MC, Andrew AS, et al. (2021). Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization. Int J Cancer. 148(5): 1077-1086. https://doi.org/10.1002/ijc.33292 PMID: 32914876